NDC product
Sheffield Triple Antibiotic Plus Pain Relief
NDC 11527-161 · Sheffield Pharmaceuticals LLC
Key facts
| Product NDC | 11527-161 |
|---|---|
| Proprietary name | Sheffield Triple Antibiotic Plus Pain Relief |
| Nonproprietary name | Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride |
| Substances | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, PRAMOXINE HYDROCHLORIDE |
| Dosage form | OINTMENT |
| Route | TOPICAL |
| Labeler | Sheffield Pharmaceuticals LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M004 |
| Pharmacologic classes | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| Marketing start | Jan 23, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: